Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Asset Utilization Ratio: 2018-2025

Historic Asset Utilization Ratio for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to 1.07.

  • Puma Biotechnology's Asset Utilization Ratio fell 6.85% to 1.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.07, marking a year-over-year decrease of 6.85%. This contributed to the annual value of 1.04 for FY2024, which is 0.27% down from last year.
  • Latest data reveals that Puma Biotechnology reported Asset Utilization Ratio of 1.07 as of Q3 2025, which was down 12.45% from 1.22 recorded in Q2 2025.
  • Puma Biotechnology's 5-year Asset Utilization Ratio high stood at 1.27 for Q2 2023, and its period low was 0.94 during Q1 2022.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 1.14 (2025), whereas its average is 1.14.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 30.80% in 2023, then declined by 17.71% in 2024.
  • Over the past 5 years, Puma Biotechnology's Asset Utilization Ratio (Quarterly) stood at 1.12 in 2021, then rose by 6.27% to 1.19 in 2022, then dropped by 8.63% to 1.09 in 2023, then fell by 2.18% to 1.06 in 2024, then decreased by 6.85% to 1.07 in 2025.
  • Its Asset Utilization Ratio was 1.07 in Q3 2025, compared to 1.22 in Q2 2025 and 1.14 in Q1 2025.